Treatment of Severe Hypercapnic Respiratory Failure Caused by SARS-CoV-2 Lung Injury with ECCO2R Using the Hemolung Respiratory Assist System
Acute respiratory distress syndrome (ARDS) due to COVID-19 leads to a high rate of mortality in the intensive care unit (ICU). A lung-protective mechanical ventilation strategy using low tidal volumes is a cornerstone to management, but uncontrolled hypercapnia is a life-threatening consequence amon...
Saved in:
Main Authors: | Ramiro Saavedra-Romero, Francisco Paz, John M. Litell, Julia Weinkauf, Carina C. Benson, Lisa Tindell, Kari Williams |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2021-01-01
|
Series: | Case Reports in Critical Care |
Online Access: | http://dx.doi.org/10.1155/2021/9958343 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Factors Affecting the Length of Hospital Stay in Hypercapnic Respiratory Failure
by: Maşide Ari, et al.
Published: (2024-12-01) -
Respiratory Protective Equipment Reconsiderations in the Age of SARS-CoV-2
by: Wei-Ren Ke, et al.
Published: (2022-01-01) -
Ecco !
by: Jean-Louis Chaléard
Published: (2008-02-01) -
Positive Retrospective SARS-CoV-2 Testing in a Case of Acute Respiratory Distress Syndrome of Unknown Etiology.
by: A. Burkett, et al.
Published: (2021-01-01) -
High-Flow Nasal Cannula in Hypercapnic Respiratory Failure: A Systematic Review and Meta-Analysis
by: Yongkang Huang, et al.
Published: (2020-01-01)